Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-16T00:15:39.772Z.
Calculation as of: 2026-09-16T00:15:39.772Z.
Quote observation: 2026-09-15T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 68104043fca0867c88664c5eafb355ad822e39baf2df0b8591a200a5e3807863
PEG RATIO
N/A
DexCom, Inc.
Market Cap
$32.62B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| DexCom, Inc. (DXCM) | $32.62B | N/A |
| Alcon Inc. (ALC)vs › | $33.05B | N/A |
| ResMed Inc. (RMD)vs › | $33.28B | N/A |
| Biogen Inc. (BIIB)vs › | $31.94B | N/A |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $31.88B | N/A |
| Centene Corp. (CNC)vs › | $33.41B | N/A |
| Waters Corporation (WAT)vs › | $31.19B | N/A |
| Zoetis Inc. (ZTS)vs › | $30.78B | N/A |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.94B | N/A |
| Quest Diagnostics Incorporated (DGX)vs › | $27.29B | N/A |
PEG Ratio
N/A
P/E Ratio
34.2
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
